[2] GHK-Cu: Tissue Repair at the Cellular Level GHK-Cu (glycine-histidine-lysine bound to copper) was first isolated from human plasma by Pickart and Thaler in 1973
Originally developed by Metabolic Pharmaceuticals in Australia, it was designed as a shorter, modified version of hGH to retain its fat-burning (lipolytic) properties
Fast-forward to today: GHK-Cu is being talked about everywhere from dermatology, longevity clinics, IV therapy, to microneedling stacks
Beyond-use periods must follow the SmPC : Generic claims about multi-dose vials remaining usable for a fixed number of days are not appropriate
[36] Vitamin B 12 deficiency is most commonly caused by malabsorption, but can also result from low intake, immune gastritis, low presence of binding proteins, or use of certain medications